Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer

Juhani Maenpaa, Valerie Wiebe, Steven Koester, Gregory Wurz, Vernon Emshoff, Robert Seymour, Pirkko Sipila, Michael DeGregorio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

An estrogen receptor-negative, multidrug-resistant MDA-MB-A1 human breast cancer cell line was grown in culture with and without a noninhibitory concentration (0.5 μM) of tamoxifen for 122 days. Tamoxifentreated and control cells were inoculated into opposite flanks of nine nude mice, where they produced measurable tumors in every case. Six of the animals were treated with tamoxifen at 500 μg/day for 22 days. Although no inhibitory nor stimulatory effect of tamoxifen was seen in vitro, tamoxifen had a clear tumor-growth-stimulating effect in mice. The most pronounced stimulatory effects were observed in the cells that had been cultured with tamoxifen. Within 3 weeks of the start of tamoxifen therapy, the cells grown in the presence of tamoxifen produced tumors with a mean size of 380 mm2, whereas the cells not pretreated with tamoxifen had tumors of 220 mm2. In contrast, in mice not receiving tamoxifen, the sizes of the tumors were 190 and 140 mm2, respectively. These preliminary results suggest that prolonged in vitro tamoxifen exposure induces cellular changes that result in tumors that are stimulated to grow faster in mice following tamoxifen treatment.

Original languageEnglish (US)
Pages (from-to)396-398
Number of pages3
JournalCancer Chemotherapy and Pharmacology
Volume32
Issue number5
DOIs
StatePublished - Sep 1993
Externally publishedYes

Fingerprint

Tamoxifen
Estrogen Receptors
Breast Neoplasms
Growth
Pharmaceutical Preparations
Tumors
Neoplasms
Cells
Cell- and Tissue-Based Therapy
Cell culture
Nude Mice
Animals
Cell Line

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Maenpaa, J., Wiebe, V., Koester, S., Wurz, G., Emshoff, V., Seymour, R., ... DeGregorio, M. (1993). Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer. Cancer Chemotherapy and Pharmacology, 32(5), 396-398. https://doi.org/10.1007/BF00735926

Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer. / Maenpaa, Juhani; Wiebe, Valerie; Koester, Steven; Wurz, Gregory; Emshoff, Vernon; Seymour, Robert; Sipila, Pirkko; DeGregorio, Michael.

In: Cancer Chemotherapy and Pharmacology, Vol. 32, No. 5, 09.1993, p. 396-398.

Research output: Contribution to journalArticle

Maenpaa, J, Wiebe, V, Koester, S, Wurz, G, Emshoff, V, Seymour, R, Sipila, P & DeGregorio, M 1993, 'Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer', Cancer Chemotherapy and Pharmacology, vol. 32, no. 5, pp. 396-398. https://doi.org/10.1007/BF00735926
Maenpaa, Juhani ; Wiebe, Valerie ; Koester, Steven ; Wurz, Gregory ; Emshoff, Vernon ; Seymour, Robert ; Sipila, Pirkko ; DeGregorio, Michael. / Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer. In: Cancer Chemotherapy and Pharmacology. 1993 ; Vol. 32, No. 5. pp. 396-398.
@article{7e49d9ffa22449278052465733f8f2d4,
title = "Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer",
abstract = "An estrogen receptor-negative, multidrug-resistant MDA-MB-A1 human breast cancer cell line was grown in culture with and without a noninhibitory concentration (0.5 μM) of tamoxifen for 122 days. Tamoxifentreated and control cells were inoculated into opposite flanks of nine nude mice, where they produced measurable tumors in every case. Six of the animals were treated with tamoxifen at 500 μg/day for 22 days. Although no inhibitory nor stimulatory effect of tamoxifen was seen in vitro, tamoxifen had a clear tumor-growth-stimulating effect in mice. The most pronounced stimulatory effects were observed in the cells that had been cultured with tamoxifen. Within 3 weeks of the start of tamoxifen therapy, the cells grown in the presence of tamoxifen produced tumors with a mean size of 380 mm2, whereas the cells not pretreated with tamoxifen had tumors of 220 mm2. In contrast, in mice not receiving tamoxifen, the sizes of the tumors were 190 and 140 mm2, respectively. These preliminary results suggest that prolonged in vitro tamoxifen exposure induces cellular changes that result in tumors that are stimulated to grow faster in mice following tamoxifen treatment.",
author = "Juhani Maenpaa and Valerie Wiebe and Steven Koester and Gregory Wurz and Vernon Emshoff and Robert Seymour and Pirkko Sipila and Michael DeGregorio",
year = "1993",
month = "9",
doi = "10.1007/BF00735926",
language = "English (US)",
volume = "32",
pages = "396--398",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer

AU - Maenpaa, Juhani

AU - Wiebe, Valerie

AU - Koester, Steven

AU - Wurz, Gregory

AU - Emshoff, Vernon

AU - Seymour, Robert

AU - Sipila, Pirkko

AU - DeGregorio, Michael

PY - 1993/9

Y1 - 1993/9

N2 - An estrogen receptor-negative, multidrug-resistant MDA-MB-A1 human breast cancer cell line was grown in culture with and without a noninhibitory concentration (0.5 μM) of tamoxifen for 122 days. Tamoxifentreated and control cells were inoculated into opposite flanks of nine nude mice, where they produced measurable tumors in every case. Six of the animals were treated with tamoxifen at 500 μg/day for 22 days. Although no inhibitory nor stimulatory effect of tamoxifen was seen in vitro, tamoxifen had a clear tumor-growth-stimulating effect in mice. The most pronounced stimulatory effects were observed in the cells that had been cultured with tamoxifen. Within 3 weeks of the start of tamoxifen therapy, the cells grown in the presence of tamoxifen produced tumors with a mean size of 380 mm2, whereas the cells not pretreated with tamoxifen had tumors of 220 mm2. In contrast, in mice not receiving tamoxifen, the sizes of the tumors were 190 and 140 mm2, respectively. These preliminary results suggest that prolonged in vitro tamoxifen exposure induces cellular changes that result in tumors that are stimulated to grow faster in mice following tamoxifen treatment.

AB - An estrogen receptor-negative, multidrug-resistant MDA-MB-A1 human breast cancer cell line was grown in culture with and without a noninhibitory concentration (0.5 μM) of tamoxifen for 122 days. Tamoxifentreated and control cells were inoculated into opposite flanks of nine nude mice, where they produced measurable tumors in every case. Six of the animals were treated with tamoxifen at 500 μg/day for 22 days. Although no inhibitory nor stimulatory effect of tamoxifen was seen in vitro, tamoxifen had a clear tumor-growth-stimulating effect in mice. The most pronounced stimulatory effects were observed in the cells that had been cultured with tamoxifen. Within 3 weeks of the start of tamoxifen therapy, the cells grown in the presence of tamoxifen produced tumors with a mean size of 380 mm2, whereas the cells not pretreated with tamoxifen had tumors of 220 mm2. In contrast, in mice not receiving tamoxifen, the sizes of the tumors were 190 and 140 mm2, respectively. These preliminary results suggest that prolonged in vitro tamoxifen exposure induces cellular changes that result in tumors that are stimulated to grow faster in mice following tamoxifen treatment.

UR - http://www.scopus.com/inward/record.url?scp=0027197673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027197673&partnerID=8YFLogxK

U2 - 10.1007/BF00735926

DO - 10.1007/BF00735926

M3 - Article

C2 - 8339392

AN - SCOPUS:0027197673

VL - 32

SP - 396

EP - 398

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 5

ER -